questionText: To ask the Secretary of State for Health and Social Care, what information national pharmacovigilance systems and clinical datasets provide on the range and relative frequency of withdrawal symptoms associated with dopamine agonist discontinuation, including anxiety, depression, autonomic symptoms, pain and craving.
heading: Drugs: Side Effects